OABI Q2 2022 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+28.9% YoY

Gross Profit

$3M37.6% margin

Operating Income

-$12M-172.3% margin

Net Income

-$10M-142.7% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-25.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$8M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$307M

Total Liabilities

$80M

Stockholders' Equity

$227M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+28.9%
Gross Profit	$3M	$6M	-51.5%
Operating Income	-$12M	-$11M	-16.5%
Net Income	-$10M	-$9M	-19.1%